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Introduction
Sarcoidosis is a multisystemic granulomatous disorder
of unknown cause that is characterized by non-caseating
epithelioid cell granulomas in affected organs,
particularly the lung, hilar lymph nodes, skin and eyes.
While the diagnosis of sarcoidosis depends on clinical
manifestations and histopathologic findings, the
presence of sarcoidal granuloma is not specific for
sarcoidosis.1 Clinically, there are many conditions
resulting in sarcoid-like granulomas that may be
interpreted either as a local reaction to a malignancy,
or as a non-caseating reaction to a focus of caseating
tuberculosis or other inflammatory disease.2 These
known granulomatous diseases should be excluded in
patients without typical symptoms of sarcoidosis.
Sarcoidosis has various presentations, such as
bilateral hilar lymphadenopathy, pulmonary infiltra-
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tion, and cutaneous and ocular lesions. Bilateral hilar
lymphadenopathy is the earliest and most common
intrathoracic manifestation of sarcoidosis.3 Although
peripheral lymphadenopathy is also observed during
the course of sarcoidosis, it is an uncommon initial
presentation.2,4 The presentation of sarcoidal
granuloma in peripheral lymph nodes, without clinical
findings suggestive of sarcoidosis elsewhere, poses a
diagnostic problem.3 Our patient had a sarcoidal
granuloma restricted to cervical lymph nodes and a
suspected diagnosis of sarcoidosis. It should be
emphasized that in patients who present with sarcoidal
granuloma in peripheral lymph nodes, a diagnosis of
sarcoidosis may only be made months or years later.
This report discusses the possibility of sarcoidal
granuloma becoming true sarcoidosis, and the
importance of follow-up in patients with sarcoidal
granuloma in peripheral lymph nodes.
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Case Report
A 39-year-old male had suffered from a progressively
increasing mass and soreness in the right neck for 2
months. He had no symptoms of dyspnea, chest pain,
fatigue, fever or weight loss. Four years previously, he
had undergone excision biopsy at the same site in the
right neck; the diagnosis, at another hospital, had been
pseudotumor. The patient’s medical records revealed
no tuberculosis or sexually transmitted diseases, and
no significant family history.
Physical examination revealed a scar over the
right upper neck skin, and multiple palpable, non-
tender, firm and mobile lymph nodes in both sides
of the neck. The largest node was about 2.0 × 1.5 cm
in the posterior triangle of the right neck. There was
no enlargement in either parotid gland, and no
splenomegaly or hepatomegaly. Magnetic resonance
imaging indicated mult ip le ,  bean-shaped,
homogeneous lymph nodes about 1.0–1.5 cm in
size in both sides of the neck (Figure 1). Preoperative
chest X-ray and electrocardiography were normal.
Laboratory data, including complete blood cell
counts, erythrocyte sedimentation rate, liver
function, renal function, serum calcium, and
urinalysis, were within normal limits. Incision biopsy
of the neck mass was performed. Histology revealed
a typical non-caseating epithelioid cell granuloma in
the lymph nodes that was compatible with sarcoidal
granuloma (Figure 2). Stains for acid-fast bacilli and
fungi were negative, and a polymerase chain reac-
tion (PCR) of the biopsy tissue was negative for
mycobacteria.
Figure 2. (A) Light microscopy revealed numerous confluent,
non-caseating granulomas in the lymph node (hematoxylin &
eosin, × 40). (B) The granuloma consisted mainly of epithelioid
cells with Langhan’s (arrows) and foreign body-type (arrowhead)
giant cells (hematoxylin & eosin, × 200).
Figure 1. (A) An axial-enhanced T2-weighted magnetic resonance
imaging scan with fat saturation showing multiple bean-shaped,
homogeneous lymph nodes in both sides of the neck (arrows).
(B) The largest node is about 1.5 × 1.0 cm in size in the posterior
triangle of the right neck (arrow).
Further evaluation with computed tomography of
the chest revealed no enlarged lymph nodes or lung
infiltration. As the patient’s neck soreness had become
worse with time, treatment was started with low-dose
prednisolone 20 mg/day. After 1 week of treatment,
the patient’s neck soreness had improved dramatically,
and the remaining enlarged lymph nodes had resolved
almost completely. The dosage of prednisolone was
tapered to 10 mg/day for another week; the drug was
then discontinued in the third week. According to
the histologic examination and clinical response to
treatment, a suspected diagnosis of sarcoidosis was
considered. No recurrence of the neck mass, or signs
of other systemic sarcoidosis, were found in the follow-
up period of 1.5 years.
Discussion
Lymphadenopathy in the head and neck often results
from nonspecific inflammation, common hyperplasia,
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tuberculosis, or tumor metastasis. Cervical lymph-
adenopathy is the most common head and neck mani-
festation of sarcoidosis, but sarcoidosis only accounts
for 1.7% of all head and neck lymphadenopathy.5,6
In fact, many more patients with sarcoidosis are
probably identified by pulmonary complaints or
abnormal chest X-ray than by initial evaluation by an
otolaryngologist. Cervical lymphadenopathy as the
sole and initial presentation of sarcoidosis is rare, and
thus may add to the difficulty in diagnosis.
The diagnosis of sarcoidosis is based on physical
examination, radiologic and laboratory findings, and
histologic examination. Most patients present with
constitutional symptoms, such as cough, dyspnea,
fever, fatigue, arthralgias, or ocular and cutaneous
symptoms; more than 90% have abnormal chest
radiography.3 Laboratory findings include an elevated
level of angiotensin-converting enzyme, hypercalcemia,
hypercalciuria, hypergammaglobulinemia, increased
erythrocyte sedimentation rate, and positive Kveim
test. Histologic examination of biopsied tissue from
the affected organ will show typical non-caseating
epithelioid granuloma.
Although the cause of sarcoidosis remains unknown,
immunologic mechanisms, genetic susceptibility, and
infectious and environmental agents have all been
implicated as possible factors. An antigen-driven, cell-
mediated immune response in tissues affected by sar-
coidosis leads to a cytokine cascade and to granuloma
formation that is thought to be mediated by stimula-
tion of CD4 T lymphocytes/T helper cells through
macrophage-presented antigen.1,3,7 Sarcoidosis is
genetically a complex disease, the most prominent
finding of which is a link to a region containing the
major histocompatibility complex on the short arm of
chromosome 6.1 A positive association with human
leukocyte antigen-B8 and -DR3 has also been re-
ported.2 Various infectious and environmental agents
may be causative factors of sarcoidosis, but such agents
have not yet been definitively identified or proven.
Since many clinical conditions can result in sarcoid-
like granuloma, the diagnosis of sarcoidosis is also
established by exclusion of other granulomatous
diseases such as Wegener’s granulomatosis,
lymphoma, carcinoma, fungal disease, foreign-body
reaction, berylliosis, syphilis, and infection with
Mycobacterium tuberculosis.1–5,7 The latter infection
is the most likely differential diagnosis, and some
authors think that M. tuberculosis may play a role in
the pathogenesis of sarcoidosis.1,3,5,7 The detection
of DNA from M. tuberculosis by PCR has been
described as a highly specific and sensitive method
for diagnosing tuberculosis; this method can also be
used to exclude M. tuberculosis as the cause of
sarcoidosis.7
Most patients with sarcoidosis have spontaneous
remission, and the disease is self-limiting. Notably,
about 10–20% of patients have chronic and progressive
disease, with a mortality rate of about 1–5%.3 Treatment
is recommended to preserve organ function, relieve
symptoms, or both, and corticosteroids are currently
the treatment of choice. Antimalarial drugs, immu-
nosuppressant drugs, immunophilins, and anti-tumor
necrosis factor drugs have recently shown some success
in the treatment of sarcoidosis.8 During follow-up,
clinicians should assess the involvement of critical
organs, such as the lungs, heart, brain, liver and
kidneys, and should provide routine evaluations every
2–4 months according to clinical need.2 Such
evaluations should include chest X-ray, pulmonary
function tests, electrocardiogram, blood counts, 24-
hour calciuria determination and urinalysis, and
serologic tests for liver function, renal function, and
calcemia. Recent promising studies of serum levels of
interleukin and tumor necrosis factor demonstrate a
correlation with sarcoidosis progression and activity.1
Known granulomatous diseases were excluded
in our patient, but a definitive diagnosis could not
be made because sarcoidosis is, by definition, a
multisystem disease. Although many patients with
lymphadenopathy may respond to corticosteroids,
the abovementioned findings in our patient led us to
suspect that sarcoidal granuloma in the cervical lymph
nodes may have been an early sign of systemic
sarcoidosis. This notion was supported by data from
case reports and several studies.2,4 For example,
Rizzato and Montemurro2 studied 43 patients with
an initial presentation of sarcoidal granuloma in
peripheral lymph nodes. A definitive diagnosis of
sarcoidosis was made in 33 patients after a median
time from presentation of 5 years; in the remaining
10 patients, the diagnosis was categorized as idiopathic
granulomatosis of the lymph nodes. The authors
concluded that, in patients presenting with sarcoidal
granuloma in peripheral lymph nodes, sarcoidosis
may be diagnosed months or years later when
characteristic manifestations appear. Apparently,
patients with sarcoidal granuloma in the peripheral
lymph nodes have a high risk of developing systemic
sarcoidosis.
In summary, sarcoidosis should be included in the
differential diagnosis of cervical lymphadenopathy.
Sarcoidal granuloma in peripheral lymph nodes may
precede a diagnosis of systemic sarcoidosis, and regular
follow-up of patients with such granuloma is highly
recommended.
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